Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Elsevier Business Intelligence

00:45 EDT 21st June 2018 | BioPortfolio

Here are the most relevant search results for "Elsevier Business Intelligence" found in our extensive news archives from over 250 global news sources.

More Information about Elsevier Business Intelligence on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Elsevier Business Intelligence for you to read. Along with our medical data and news we also list Elsevier Business Intelligence Clinical Trials, which are updated daily. BioPortfolio also has a large database of Elsevier Business Intelligence Companies for you to search.

Showing News Articles 1–25 of 1,700+ from Elsevier Business Intelligence

Wednesday 20th June 2018

Amarin gets rights to Mochida IP

Mochida Pharmaceutical Co. Ltd. granted Amarin Corp. PLC exclusive rights to certain intellectual property for use in develop...

Freeline closes £88.4mm Series B round

Freeline Therapeutics Ltd. raised £88.4mm ($117.4mm) through its Series B round. Series A investor Syncona led with an £85m...

Verastem grosses $43mm through private placement

Verastem Inc. (developing therapies that modulate the tumor microenvironment) grossed $43mm through the private sale of 7.17m...

Haemonetics enters $700mm loan agreement

Haemonetics Corp. (blood management devices and services) entered into a $700mm loan agreement, which includes a $350mm unsec...

UK Industry Raises Conflict of Interest Concerns Over NICE’s PRIMA Service

PRIMA, the new service the National Institute for Health and Care Excellence offers to review economic models, must not be......

SPCs Can Be Granted In UK After Brexit Transition Period, Says Withdrawal Agreement

If requests for supplementary protection certificates are filed in the UK during a Brexit transition period, and the grant pr...

Dermatology-focused Verrica nets $69.8mm in IPO

Verrica Pharmaceuticals Inc. (topical treatments for skin diseases) netted $69.8mm in its initial public offering of 5mm shar...

Faster Submissions For Orphan Designation Possible As EMA’s Online Portal Goes Live

The new portal is expected to provide an improved method for applying for and managing EU orphan drug designations. ...

Tuesday 19th June 2018

Despite Recession, Global Biosimilars Market Grew Over 40% 2010-2011, Set To Reach $3.6B By 2016

Despite a global recession, the market for Biosimilars grew over 40% from 2010 to 2011, and is expected to grown more than 40...

BridgeBio forms, commits $20mm in funding to Fortify Therapeutics

BridgeBio Pharma has launched Fortify Therapeutics with $20mm in financing.

VNS device company electroCore files for IPO

Noninvasive vagus nerve stimulation (nVNS) device company electroCore LLC (focused on neurology and rheumatology) filed for i...

NeuroVive licenses BridgeBio rights to LHON program

NeuroVive Pharmaceutical AB licensed BridgeBio Pharma exclusive rights to develop its NVP015 program for Leber's hereditary o...

Decibel Therapeutics raises $55mm in Series C round

Decibel Therapeutics raised $55mm in its Series C financing round. All prior investors participated including Third Rock Ven...

Emulate raises $36mm in Series C round from Founders Fund

Emulate Inc. raised $36mm in its Series C financing round led by Founders Fund. New investors ALS Investment Fund, SciFi VC, ...

Kallyope, Novo Nordisk collaborate on development of obesity and diabetes therapies

Kallyope Inc. and Novo Nordisk AS are teaming up to discover and develop peptide therapeutics to treat obesity and diabetes. ...

GI Partners acquires donor sperm and egg bank California Cryobank, plans to combine with CBR

Private equity firm GI Partners agreed to acquire privately held donor sperm and egg bank California Cryobank Inc. (CCB) from...

AMAG divests its Cord Blood Registry division to GI Partners for $530mm

Private equity firm GI Partners agreed to acquire AMAG Pharmaceuticals Inc.'s Cord Blood Registry Inc. (CBR) unit, a newborn ...

340B Legislative Reforms: Where Do We Go From Here?

Third US Senate committee hearing on 340B reforms focuses on the need for legislation requiring that providers report the dru...

Eagle Will Be Last Firm To Bypass FDA's Orphan Drug Exclusivity Requirement

Court orders US FDA to award Bendeka seven years of exclusivity without requiring clinical superiority test; law codifying FD...

Increase In Antibacterial R&D Prompts EMA Proposal For Improved Guidance

Following a resurgence of activity in the field of antibacterial products, the European Medicines Agency has proposed merging...

‘Micro’ Firms Avoid UK Drug Verification System Fees, As More Countries Join European Hub

Very small companies are to be exempt from the fee for registering with the UK’s verification system that will be... &...

High Expectations For New U.S. Biosimilar Pharmaceuticals Following FDA Guidance Documents

In light of the upcoming FDA guidance for biosimilar approval, Novation has released a white paper, "Biosimilars –...

FDA Issues Draft Guidance On Biosimilar Product Development

The U.S. Food and Drug Administration recently issued three draft guidance documents on biosimilar product development to ass...

Monday 18th June 2018

Wize grants HPGC Medical rights to LO2A eye drops in China

Wize Pharma Inc. licensed Harbin Pharmaceutical Group’s HPGC Medical Co. Ltd. exclusive rights to distribute the ophthalmic...

BridgeBio gets rights to Alexion's ALXN1101

BridgeBio Pharma acquired from Alexion Pharmaceuticals Inc. ALXN1101 (cyclic pyranopterin monophosphate) for molybdenum cofac...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks